Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kosuke Okasho"'
Autor:
Yu Miyazaki, Takayuki Goto, Xin Li, Kenji Nakayama, Kosuke Okasho, Masashi Takeda, Kei Mizuno, Hiroko Kimura, Masayuki Uegaki, Takayuki Sumiyoshi, Yuki Teramoto, Shusuke Akamatsu, Takashi Kobayashi, Osamu Ogawa, Takahiro Inoue
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3328-3342 (2023)
Abstract Using new castration‐resistant prostate cancer (CRPC) cell lines developed from LNCaP cells as a model for CRPC, we searched for novel biomarkers by analyzing the proteins secreted in culture supernatants. The results showed that the level
Externí odkaz:
https://doaj.org/article/badf677dbd6e4168aee5171531b22327
Autor:
Takahiro Nagai, Naoki Terada, Masato Fujii, Yasuhisa Nagata, Kozue Nakahara, Shoichiro Mukai, Kosuke Okasho, Yuki Kamiyama, Shusuke Akamatsu, Takashi Kobayashi, Kei Iida, Masatsugu Denawa, Masatoshi Hagiwara, Takahiro Inoue, Osamu Ogawa, Toshiyuki Kamoto
Publikováno v:
Cancer Reports, Vol 6, Iss 2, Pp n/a-n/a (2023)
Abstract Background Several treatment strategies use upfront chemotherapy or androgen receptor axis‐targeting therapies for metastatic prostate cancer. However, there are no useful biomarkers for selecting appropriate patients who urgently require
Externí odkaz:
https://doaj.org/article/cd24ac9cd5a24e39b79a1d9f3a01026d
Autor:
Yu Miyazaki, Yuki Teramoto, Shinsuke Shibuya, Takayuki Goto, Kosuke Okasho, Kei Mizuno, Masayuki Uegaki, Takeshi Yoshikawa, Shusuke Akamatsu, Takashi Kobayashi, Osamu Ogawa, Takahiro Inoue
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 5, p 601 (2019)
Aldo-keto reductase family 1 member C3 (AKR1C3) is an enzyme in the steroidogenesis pathway, especially in formation of testosterone and dihydrotestosterone, and is believed to have a key role in promoting prostate cancer (PCa) progression, particula
Externí odkaz:
https://doaj.org/article/8c561ccfe31b4f779622a01d1e2db0c1
Autor:
Yu Miyazaki, Takayuki Goto, Xin Li, Kenji Nakayama, Kosuke Okasho, Masashi Takeda, Kei Mizuno, Hiroko Kimura, Masayuki Uegaki, Takayuki Sumiyoshi, Yuki Teramoto, Shusuke Akamatsu, Takashi Kobayashi, Osamu Ogawa, Takahiro Inoue
Publikováno v:
Cancer Medicine. 12:3328-3342
Publikováno v:
Transl Androl Urol
With wide availability of potent androgen receptor targeted agents (ARTAs), the incidence of treatment-related neuroendocrine prostate cancer (t-NEPC) has been dramatically increasing. However, there is no standard effective treatment for this diseas
Autor:
Takahiro Nagai, Naoki Terada, Masato Fujii, Yasuhisa Nagata, Kozue Nakahara, Shoichiro Mukai, Kosuke Okasho, Yuki Kamiyama, Shusuke Akamatsu, Takashi Kobayashi, Kei Iida, Masatsugu Denawa, Masatoshi Hagiwara, Takahiro Inoue, Osamu Ogawa, Toshiyuki Kamoto
Publikováno v:
Cancer Reports. 6
Autor:
Tomohiro Fukui, Dong Lin, Takayuki Goto, Takuro Sunada, Yen-Yi Lin, Hiroko Kimura, Colin Collins, Yuki Kamiyama, Takayuki Sumiyoshi, Kosuke Okasho, Takashi Kobayashi, Osamu Ogawa, Xin Li, Shusuke Akamatsu, Yuzhuo Wang, Kei Mizuno, Takahiro Inoue
Publikováno v:
Cancer Science
The prevalence of neuroendocrine prostate cancer (NEPC) arising from adenocarcinoma (AC) upon potent androgen receptor (AR) pathway inhibition is increasing. Deeper understanding of NEPC biology and development of novel therapeutic agents are needed.
Autor:
Kosuke Okasho, Kei Mizuno, Takashi Kobayashi, Tomomi Kamba, Toshinari Yamasaki, Xin Li, Takayuki Goto, Yu Miyazaki, Takahiro Inoue, Shusuke Akamatsu, Osamu Ogawa, Yuki Makino, Naoki Terada, Akihiro Fujimoto, Takayuki Sumiyoshi, Noriaki Utsunomiya
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports
Scientific Reports
The therapeutic landscape of castration-resistant prostate cancer (CRPC) has rapidly expanded. There is a need to develop noninvasive biomarkers to guide treatment. We established a highly sensitive method for analyzing androgen receptor gene (AR) co
Autor:
Kosuke Okasho, Kei Mizuno, Yuki Teramoto, Shinsuke Shibuya, Takashi Kobayashi, Masayuki Uegaki, Shusuke Akamatsu, Takayuki Goto, Yu Miyazaki, Takahiro Inoue, Takeshi Yoshikawa, Osamu Ogawa
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 5, p 601 (2019)
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 8; Issue 5; Pages: 601
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 8; Issue 5; Pages: 601
Aldo-keto reductase family 1 member C3 (AKR1C3) is an enzyme in the steroidogenesis pathway, especially in formation of testosterone and dihydrotestosterone, and is believed to have a key role in promoting prostate cancer (PCa) progression, particula
Autor:
Kaoru, Murakami, Noboru, Shibasaki, Akihiro, Hamada, Atsushi, Sengiku, Kosuke, Okasho, Atsuro, Sawada, Hiroaki, Kawanishi, Kazuhiro, Okumura, Hidehiro, Okumura
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 58(2)
A 54-year-old man presented with pollakiuria and dysuria. Ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) showed a retroperitoneal tumor 10 cm in diameter. Pathological examination of a transrectal biopsy specimen obta